Twisted gastrulation, a bmp antagonist, exacerbates podocyte injury

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Yamada, Sachiko ^a   Nakamura, Jin ^a   Asada, Misako ^a   Takase, Masayuki ^a   Matsusaka, Taiji ^b   Iguchi, Taku ^a   Yamada, Ryo ^a   Tanaka, Mari ^a   Higashi, Atsuko Y ^a   Okuda, Tomohiko ^a   Asada, Nariaki ^a   Fukatsu, Atsushi ^c   Kawachi, Hiroshi ^d   Graf, Daniel ^e   Muso, Eri ^f   Kita, Toru ^g   Kimura, Takeshi ^a   Pastan, Ira ^h   Economides, Aris N ⁱ   Yanagita, Motoko ^a  

^a KYOTO UNIVERSITY   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Yachiyo Hospital   (Japan)

^d NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^e UNIVERSITY OF ZURICH   (Switzerland)

^f Kitano Hospital   (Japan)

^g KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^h NATIONAL CANCER INSTITUTE   (United States)

ⁱ REGENERON PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; BONE MORPHOGENETIC PROTEIN; OSTEOGENIC PROTEIN 1; SMAD PROTEIN; TWISTED GASTRULATION PROTEIN; UNCLASSIFIED DRUG; BMP7 PROTEIN, MOUSE; PROTEIN; TWISTED GASTRULATION PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL DAMAGE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; GLOMERULAR PARIETAL CELL; HYPERLIPIDEMIA; HYPOALBUMINEMIA; KIDNEY CELL; KIDNEY INJURY; MOUSE; NEPHRON; NONHUMAN; PODOCYTE; PODOCYTE INJURY; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; GLOMERULUS; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY;

ANIMALS; BONE MORPHOGENETIC PROTEIN 7; CELL DIFFERENTIATION; CELLS, CULTURED; KIDNEY GLOMERULUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEPHRONS; PODOCYTES; PROTEINS; SIGNAL TRANSDUCTION; SMAD PROTEINS;

EID: 84897798847     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089135     Document Type: Article

References (50)

1. LeHir M, Kriz W (2007) New insights into structural patterns encountered in glomerulosclerosis. Curr Opin Nephrol Hypertens 16: 184-191.
2. D'Agati VD (2008) Podocyte injury in focal segmental glomerulosclerosis: Lessons from animal models (a play in five acts). Kidney Int 73: 399-406.
3. Wiggins RC (2007) The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int 71: 1205-1214.
4. Barisoni L, Schnaper HW, Kopp JB (2007) A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases. Clin J Am Soc Nephrol 2: 529-542.
5. Mundel P, Shankland SJ (2002) Podocyte biology and response to injury. J Am Soc Nephrol 13: 3005-3015. (Pubitemid 35386921)
6. Alpers CE, Hudkins KL (2011) Mouse models of diabetic nephropathy. Curr Opin Nephrol Hypertens 20: 278-284.
7. Schonenberger E, Ehrich JH, Haller H, Schiffer M (2011) The podocyte as a direct target of immunosuppressive agents. Nephrol Dial Transplant 26: 18-24.
8. Dudley AT, Lyons KM, Robertson EJ (1995) A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev 9: 2795-2807.
9. Luo G, Hofmann C, Bronckers AL, Sohocki M, Bradley A, et al. (1995) BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev 9: 2808-2820.
10. Gould SE, Day M, Jones SS, Dorai H (2002) BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells. Kidney Int 61: 51-60. (Pubitemid 34075130)
11. Leeuwis JW, Nguyen TQ, Chuva de Sousa Lopes SM, van der Giezen DM, van der Ven K, et al. (2011) Direct visualization of Smad1/5/8-mediated transcriptional activity identifies podocytes and collecting ducts as major targets of BMP signalling in healthy and diseased kidneys. J Pathol 224: 121-132.
12. Sugimoto H, Grahovac G, Zeisberg M, Kalluri R (2007) Renal fibrosis and glomerulosclerosis in a new mouse model of diabetic nephropathy and its regression by bone morphogenic protein-7 and advanced glycation end product inhibitors. Diabetes 56: 1825-1833. (Pubitemid 47025452)
13. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, et al. (2003) BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 9: 964-968. (Pubitemid 36889942)
14. Zeisberg M, Bottiglio C, Kumar N, Maeshima Y, Strutz F, et al. (2003) Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. Am J Physiol Renal Physiol 285: F1060-1067. (Pubitemid 37421041)
15. Wang S, de Caestecker M, Kopp J, Mitu G, Lapage J, et al. (2006) Renal bone morphogenetic protein-7 protects against diabetic nephropathy. J Am Soc Nephrol 17: 2504-2512. (Pubitemid 44300966)
16. Mitu GM, Wang S, Hirschberg R (2007) BMP7 is a podocyte survival factor and rescues podocytes from diabetic injury. Am J Physiol Renal Physiol 293: F1641-1648. (Pubitemid 350086001)
17. De Petris L, Hruska KA, Chiechio S, Liapis H (2007) Bone morphogenetic protein-7 delays podocyte injury due to high glucose. Nephrol Dial Transplant 22: 3442-3450. (Pubitemid 350212514)
18. Walsh DW, Godson C, Brazil DP, Martin F (2010) Extracellular BMP-antagonist regulation in development and disease: tied up in knots. Trends Cell Biol 20: 244-256.
19. Massague J, Chen YG (2000) Controlling TGF-beta signaling. Genes Dev 14: 627-644.
20. Yanagita M (2005) BMP antagonists: their roles in development and involvement in pathophysiology. Cytokine Growth Factor Rev 16: 309-317.
21. Yanagita M (2006) Modulator of bone morphogenetic protein activity in the progression of kidney diseases. Kidney Int 70: 989-993.
22. Yanagita M (2009) BMP modulators regulate the function of BMP during body patterning and disease progression. Biofactors 35: 113-119.
23. Yanagita M, Oka M, Watabe T, Iguchi H, Niida A, et al. (2004) USAG-1: a bone morphogenetic protein antagonist abundantly expressed in the kidney. Biochem Biophys Res Commun 316: 490-500. (Pubitemid 38338618)
24. Yanagita M, Okuda T, Endo S, Tanaka M, Takahashi K, et al. (2006) Uterine sensitization-associated gene-1 (USAG-1), a novel BMP antagonist expressed in the kidney, accelerates tubular injury. J Clin Invest 116: 70-79. (Pubitemid 43121792)
25. Tanaka M, Endo S, Okuda T, Economides AN, Valenzuela DM, et al. (2008) Expression of BMP-7 and USAG-1 (a BMP antagonist) in kidney development and injury. Kidney Int 73: 181-191.
26. Tanaka M, Asada M, Higashi AY, Nakamura J, Oguchi A, et al. (2010) Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome. J Clin Invest 120: 768-777.
27. Larrain J, Oelgeschlager M, Ketpura NI, Reversade B, Zakin L, et al. (2001) Proteolytic cleavage of Chordin as a switch for the dual activities of Twisted gastrulation in BMP signaling. Development 128: 4439-4447. (Pubitemid 33130425)
28. Chang C, Holtzman DA, Chau S, Chickering T, Woolf EA, et al. (2001) Twisted gastrulation can function as a BMP antagonist. Nature 410: 483-487. (Pubitemid 32240049)
29. Harland RM (2001) Developmental biology. A twist on embryonic signalling. Nature 410: 423-424.
30. Oelgeschlager M, Larrain J, Geissert D, De Robertis EM (2000) The evolutionarily conserved BMP-binding protein Twisted gastrulation promotes BMP signalling. Nature 405: 757-763. (Pubitemid 30407840)
31. Ross JJ, Shimmi O, Vilmos P, Petryk A, Kim H, et al. (2001) Twisted gastrulation is a conserved extracellular BMP antagonist. Nature 410: 479-483. (Pubitemid 32240048)
32. Scott IC, Blitz IL, Pappano WN, Maas SA, Cho KW, et al. (2001) Homologues of Twisted gastrulation are extracellular cofactors in antagonism of BMP signalling. Nature 410: 475-478. (Pubitemid 32240047)
33. Zakin L, De Robertis EM (2004) Inactivation of mouse Twisted gastrulation reveals its role in promoting Bmp4 activity during forebrain development. Development 131: 413-424. (Pubitemid 38181379)
34. Matsusaka T, Xin J, Niwa S, Kobayashi K, Akatsuka A, et al. (2005) Genetic engineering of glomerular sclerosis in the mouse via control of onset and severity of podocyte-specific injury. J Am Soc Nephrol 16: 1013-1023. (Pubitemid 41710312)
35. Mundel P, Reiser J, Zuniga Mejia Borja A, Pavenstadt H, Davidson GR, et al. (1997) Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 236: 248-258. (Pubitemid 27452369)
36. Shankland SJ, Pippin JW, Reiser J, Mundel P (2007) Podocytes in culture: past, present, and future. Kidney Int 72: 26-36. (Pubitemid 47014453)
37. Kerjaschki D, Sharkey DJ, Farquhar MG (1984) Identification and characterization of podocalyxin - the major sialoprotein of the renal glomerular epithelial cell. The Journal of cell biology 98: 1591-1596. (Pubitemid 14126988)
38. Takemoto M, Asker N, Gerhardt H, Lundkvist A, Johansson BR, et al. (2002) A new method for large scale isolation of kidney glomeruli from mice. The American journal of pathology 161: 799-805. (Pubitemid 34988366)
39. Nielsen JS, McNagny KM (2009) The role of podocalyxin in health and disease. J Am Soc Nephrol 20: 1669-1676.
40. Yu PB, Hong CC, Sachidanandan C, Babitt JL, Deng DY, et al. (2008) Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol 4: 33-41. (Pubitemid 350273653)
41. Hong CC, Yu PB (2009) Applications of small molecule BMP inhibitors in physiology and disease. Cytokine Growth Factor Rev 20: 409-418.
42. Kreitman RJ, Bailon P, Chaudhary VK, FitzGerald DJ, Pastan I (1994) Recombinant immunotoxins containing anti-Tac(Fv) and derivatives of Pseudomonas exotoxin produce complete regression in mice of an interleukin-2 receptor-expressing human carcinoma. Blood 83: 426-434. (Pubitemid 24030568)
43. Petryk A, Anderson RM, Jarcho MP, Leaf I, Carlson CS, et al. (2004) The mammalian twisted gastrulation gene functions in foregut and craniofacial development. Dev Biol 267: 374-386. (Pubitemid 38328579)
44. Sun M, Forsman C, Sergi C, Gopalakrishnan R, O'Connor MB, et al. (2010) The expression of twisted gastrulation in postnatal mouse brain and functional implications. Neuroscience 169: 920-931.
45. Ikeya M, Fukushima K, Kawada M, Onishi S, Furuta Y, et al. (2010) Cv2, functioning as a pro-BMP factor via twisted gastrulation, is required for early development of nephron precursors. Dev Biol 337: 405-414.
46. Larman BW, Karolak MJ, Adams DC, Oxburgh L (2009) Chordin-like 1 and twisted gastrulation 1 regulate BMP signaling following kidney injury. Journal of the American Society of Nephrology : JASN 20: 1020-1031.
47. Appel D, Kershaw DB, Smeets B, Yuan G, Fuss A, et al. (2009) Recruitment of podocytes from glomerular parietal epithelial cells. Journal of the American Society of Nephrology : JASN 20: 333-343.
48. Ohse T, Pippin JW, Chang AM, Krofft RD, Miner JH, et al. (2009) The enigmatic parietal epithelial cell is finally getting noticed: a review. Kidney international 76: 1225-1238.
49. Passa O, Tsalavos S, Belyaev NN, Petryk A, Potocnik AJ, et al. (2011) Compartmentalization of bone morphogenetic proteins and their antagonists in lymphoid progenitors and supporting microenvironments and functional implications. Immunology 134: 349-359.
50. Tsalavos S, Segklia K, Passa O, Petryk A, O'Connor MB, et al. (2011) Involvement of twisted gastrulation in T cell-independent plasma cell production. J Immunol 186: 6860-6870.